BIORA THERAPEUTICS, INC.

Analyst Reco. Biora Therapeutics, Inc.

Equities

BIOR

US74319F3055

Market Closed - Nasdaq Other stock markets 16:00:00 2024-06-27 EDT			5-day change	1st Jan Change
0.6447 ^USD	+1.13%		-6.84%	-52.24%

06-07	Biora Therapeutics Provides Information to the Shareholders	CI
06-07	Biora Therapeutics, Inc. Appoints Jeffrey A. Ferrell as Director	CI

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

HC Wainwright Adjusts Biora Therapeutics Price Target to $50 From $65, Maintains Buy Rating	23-10-02	MT
HC Wainwright Adjusts Price Target on Biora Therapeutics to $6 From $4, Reiterates Buy Rating	22-07-15	MT
CORRECTION : BTIG Analyst Assumes Biora Therapeutics at Buy, Price Target $4	22-05-20	MT
BTIG Assumes Progenity at Buy, Price Target $12	22-05-03	MT
PROGENITY : HC Wainwright Starts Progenity at Buy with $4 Price Target	21-10-14	MT
PROGENITY : Raymond James Downgrades Progenity to Market Perform From Outperform	21-06-03	MT
PROGENITY : Piper Sandler Adjusts Progenity's Price Target to $3 From $8, Maintains Overweight Rating	21-06-03	MT
PROGENITY : Baird Lowers Progenity to Neutral From Outperform, Price Target to $2 From $4	21-06-03	MT
PROGENITY : Wells Fargo Adjusts Progenity PT to $2 From $4, Maintains Underweight Rating	21-05-17	MT
PROGENITY : Raymond James Adjusts Price Target on Progenity to $7 From $10, Maintains Outperform Rating	21-05-14	MT
PROGENITY : Baird Adjusts Progenity's Price Target to $4 From $6, Keeps Outperform Rating	21-05-14	MT
PROGENITY : Wells Fargo Downgrades Progenity to Underweight From Overweight, Adjusts Price Target to $5 From $11	21-02-08	MT
PROGENITY : Raymond James Adjusts Progenity PT to $10 From $15, Maintains Outperform Rating	20-11-10	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Our Free Content Help you Secure and Increase the Performance of Your Investments

Securing my Investments

fermer